Skip to main content
Premium Trial:

Request an Annual Quote

Scienion, Genomica Jointly Developing Printing Technology for Molecular Applications

NEW YORK (GenomeWeb News) – Scienion and Genomica Unipersonal today said they are expanding their partnership to offer a jointly developed printing plate technology platform that combines each firm's technology.

The new platform integrates Scienion's non-contact arraying surface technologies with Genomica's multiplex PCR technology and microarray technology, resulting in the advancement of new molecular applications, the companies said. They added they will offer services to the microarray space based on the new technology. These new services will range from assay development to microarray manufacturing.

Scienion CEO Holger Eickhoff said in a statement that the combination of the companies' technologies is a "perfect match. We are aiming to speed up the development of better and safer in vitro diagnostics and will offer joint technology solutions for the benefit of users and last but not least also for patients.”

Scienion is based in Berlin with a US subsidiary in Princeton, NJ, and provides systems and services for contact-free printing of biological and chemical agents. Genomica, headquartered in Madrid, develops in vitro diagnostic products and services for genetic identification.

The partners started working together in 2009 and in 2011. Genomica launched array-based tests for sepsis and enteric diseases developed from the collaboration, as GenomeWeb Daily News' sister publication BioArray News previously reported.

The Scan

Harvard Team Report One-Time Base Editing Treatment for Motor Neuron Disease in Mice

A base-editing approach restored SMN levels and improved motor function in a mouse model of spinal muscular atrophy, a new Science paper reports.

International Team Examines History of North American Horses

Genetic and other analyses presented in Science find that horses spread to the northern Rockies and Great Plains by the first half of the 17th century.

New Study Examines Genetic Dominance Within UK Biobank

Researchers analyze instances of genetic dominance within UK Biobank data, as they report in Science.

Cell Signaling Pathway Identified as Metastasis Suppressor

A new study in Nature homes in on the STING pathway as a suppressor of metastasis in a mouse model of lung cancer.